Cargando…

Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial

INTRODUCTION: Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening skin disease. The global Effisayil 1 study investigated the efficacy and safety of spesolimab, a humanized monoclonal antibody targeting the IL-36 receptor, in patients experiencing GPP flare. This analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Tsen-Fang, Zheng, Min, Ding, Yangfeng, Song, Zhiqi, Liu, Quanzhong, Chen, Ying, Hu, Hanzhao, Xu, Jinhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689646/ https://www.ncbi.nlm.nih.gov/pubmed/37840119 http://dx.doi.org/10.1007/s13555-023-01037-4

Ejemplares similares

Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis
por: Morita, Akimichi, et al.
Publicado: (2022)

Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double‐blind, placebo‐controlled Effisayil™ 1 study
por: Morita, Akimichi, et al.
Publicado: (2022)

Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
por: Choon, Siew Eng, et al.
Publicado: (2021)

Rapid response of spesolimab in biologics – failure patient with generalized pustular psoriasis flare
por: Jiang, Meng, et al.
Publicado: (2023)

Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
por: Shao, Shuai, et al.
Publicado: (2022)

Clinical analysis of generalized pustular psoriasis in Chinese patients: A retrospective study of 110 patients
por: Zheng, Jianfeng, et al.
Publicado: (2021)

A Case of Ceftriaxone-Induced Acute Generalized Exanthematous Pustulosis/Generalized Pustular Psoriasis Overlap
por: Zheng, Jianfeng, et al.
Publicado: (2018)

Successful treatment of juvenile generalized pustular psoriasis with infliximab therapy: two case reports
por: Lu, Jiajing, et al.
Publicado: (2020)

Secukinumab in Generalized Pustular Psoriasis
por: Madanagobalane, Shraddha
Publicado: (2018)

Pathophysiology of Generalized Pustular Psoriasis
por: Marrakchi, Slaheddine, et al.
Publicado: (2022)

Diagnosis of Generalized Pustular Psoriasis
por: Fujita, Hideki, et al.
Publicado: (2022)

Diagnosis and screening of patients with generalized pustular psoriasis
por: Ly, Karen, et al.
Publicado: (2019)

Spesolimab: First Approval
por: Blair, Hannah A.
Publicado: (2022)

Treatment Options and Goals for Patients with Generalized Pustular Psoriasis
por: Krueger, James, et al.
Publicado: (2022)

Generalized pustular psoriasis (von Zumbusch)()
por: Romiti, Ricardo, et al.
Publicado: (2022)

Circulating Metabolomic Signature in Generalized Pustular Psoriasis Blunts Monocyte Hyperinflammation by Triggering Amino Acid Response
por: Yu, Ning, et al.
Publicado: (2021)

Correction to: Spesolimab: First Approval
por: Blair, Hannah A.
Publicado: (2022)

Successful Treatment of Recurrent Pustular Psoriasis of Pregnancy with Secukinumab: A Case Report
por: LIU, Na, et al.
Publicado: (2020)

Serum Procalcitonin and Presepsin Levels in Patients with Generalized Pustular Psoriasis
por: Nagai, Makoto, et al.
Publicado: (2018)

Pediatric COVID-19 patient with exacerbated generalized pustular psoriasis
por: Pala, Erdal, et al.
Publicado: (2021)

Etanercept in the Treatment of Generalized Annular Pustular Psoriasis
por: Lo Schiavo, Ada, et al.
Publicado: (2012)

Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis
por: Sussman, Morgan, et al.
Publicado: (2021)

The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis
por: Zheng, Min, et al.
Publicado: (2022)

Clinical Disease Measures in Generalized Pustular Psoriasis
por: Burden, A. David, et al.
Publicado: (2022)

Clinical Course and Characteristics of Generalized Pustular Psoriasis
por: Choon, Siew Eng, et al.
Publicado: (2022)

Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases
por: Haskamp, Stefan, et al.
Publicado: (2020)

Variant Analysis of CARD14 in a Chinese Han Population with Psoriasis Vulgaris and Generalized Pustular Psoriasis
por: Qin, Peipei, et al.
Publicado: (2014)

Spesolimab use in treatment of pyoderma gangrenosum
por: Guénin, Sophie H., et al.
Publicado: (2023)

Recurrent generalized pustular psoriasis possibly triggered by apremilast
por: Wang, Wen-Ming, et al.
Publicado: (2020)

Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity
por: Samotij, Dominik, et al.
Publicado: (2021)

An update on genetic basis of generalized pustular psoriasis (Review)
por: Zhou, Jiahong, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares
por: Choon, Siew Eng, et al.
Publicado: (2023)

Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results
por: Okubo, Yukari, et al.
Publicado: (2022)

Generalized pustular psoriasis treated with apremilast in a patient with multiple medical comorbidities
por: Jeon, Caleb, et al.
Publicado: (2017)

IgA nephropathy in a patient receiving infliximab for generalized pustular psoriasis
por: Segawa, Yuka, et al.
Publicado: (2020)

Generalized pustular psoriasis rapidly and successfully treated with ixekizumab in a Caucasian patient
por: Megna, Matteo, et al.
Publicado: (2022)

Long‐term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open‐label, phase 3 study (UNCOVER‐J)
por: Okubo, Y., et al.
Publicado: (2018)

Telmisartan aggravates pustular psoriasis
por: Keerthi, Subramaniam, et al.
Publicado: (2015)

Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP)
por: Burden, A. David, et al.
Publicado: (2022)

Serum Cytokines Correlated with The Disease Severity of Generalized Pustular Psoriasis
por: Yamamoto, Masaaki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sjkqqsgt2gn6qr0sfihcd71bea